|
SAVA
|
Cassava Sciences, Inc.
|
3.07%
|
US
|
NASDAQ
|
|
AVXL
|
Anavex Life Sciences Corp.
|
2.09%
|
US
|
NASDAQ
|
|
9996
|
Peijia Medical Ltd
|
1.48%
|
HK
|
HK
|
|
ALEC
|
Alector, Inc.
|
1.38%
|
US
|
NASDAQ
|
|
AXGN
|
AxoGen, Inc.
|
1.20%
|
US
|
NASDAQ
|
|
BTAI
|
BioXcel Therapeutics, Inc.
|
1.19%
|
US
|
NASDAQ
|
|
VNDA
|
Vanda Pharmaceuticals Inc.
|
1.11%
|
US
|
NASDAQ
|
|
WVE
|
WAVE Life Sciences Ltd.
|
1.09%
|
US
|
NASDAQ
|
|
EWTX
|
Edgewise Therapeutics, Inc.
|
1.06%
|
US
|
NASDAQ
|
|
DYN
|
Dyne Therapeutics, Inc.
|
0.92%
|
US
|
NASDAQ
|
|
268600
|
Cellivery Therapeutics Inc
|
0.66%
|
KR
|
KQ
|
|
DSGN
|
Design Therapeutics, Inc.
|
0.66%
|
US
|
NASDAQ
|
|
VYGR
|
Voyager Therapeutics, Inc.
|
0.54%
|
US
|
NASDAQ
|
|
CLPT
|
ClearPoint Neuro Inc.
|
0.50%
|
US
|
NASDAQ
|
|
ANNX
|
Annexon, Inc.
|
0.46%
|
US
|
NASDAQ
|
|
KMPH
|
KemPharm, Inc.
|
0.39%
|
US
|
NASDAQ
|
|
XERS
|
Xeris Pharmaceuticals, Inc.
|
0.38%
|
US
|
NASDAQ
|
|
MRNS
|
Marinus Pharmaceuticals, Inc.
|
0.37%
|
US
|
NASDAQ
|
|
ATHA
|
Athira Pharma, Inc.
|
0.37%
|
US
|
NASDAQ
|